Home > Insider Trading > Filing (0001012975-10-000380)

Filing Details

Accession Number:: 0001012975-10-000380
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-01 16:18:37
Reporting Period:: 2010-10-28

Filing Date:: 2010-11-01
Accepted Time:: 2010-11-01 16:18:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1298521	Trubion Pharmaceuticals Inc	TRBN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1054117	Steven Lazarus	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1117120	Arch Venture Fund V Lp	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1161740	Arch V Entrepreneurs Fund Lp	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1219039	Keith Crandell	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1219042	Robert Nelsen	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1219043	Clinton Bybee	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1222239	Healthcare Focus Fund Lp	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1274406	Arch Venture Partners V Lp	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No
1274408	Arch Venture Partners V Llc	8725 West Higgins Road, Suite 290 Chicago IL 60631	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2010-10-28	2,209,741	$0.00	No	4	S	Direct
Common Stock	Disposition	2010-10-28	14,503	$0.00	No	4	S	Direct
Common Stock	Disposition	2010-10-28	132,802	$0.00	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Securities disposed of pursuant to that certain Agreement and Plan of Merger dated as of August 12, 2010 (attached as Exhibit 2.1 to Trubion's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 13, 2010), as amended, among the issuer and Emergent BioSolutions Inc. ("Emergent"), and certain affiliates, in exchange for (a) an aggregate of $3,217,367.79 cash, (b) 386,791 shares of Emergent common stock having a market value of $18.26 per share on the effective date of the merger and (c) 2,357,046 contingent value rights, which represent the right to receive possible additional cash payments.
Securities held of record by ARCH Venture Fund V, L.P. ("ARCH V"). ARCH Venture Partners V, L.P. (the "GPLP"), as the sole general partner of ARCH V, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLP disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLP does not have an actual pecuniary interest. ARCH Venture Partners V, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLLC disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLLC does not have an actual pecuniary interest.
Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by ARCH V. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by ARCH V in which he does not have an actual pecuniary interest.
Securities held of record by ARCH V Entrepreneurs Fund, L.P. ("Entrepreneurs"). The GPLP, as the sole general partner of Entrepreneurs, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLP disclaims beneficial ownership of all shares held of record by Entrepreneurs in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLLC disclaims beneficial ownership of all shares held of record by Entrepreneurs in which the GPLLC does not have an actual pecuniary interest.
Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Entrepreneurs in which he does not have an actual pecuniary interest.
Securities held of record by Healthcare Focus Fund, L.P. ("Healthcare"). The GPLP, as the sole general partner of Healthcare, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLP disclaims beneficial ownership of all shares held of record by Healthcare in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLLC disclaims beneficial ownership of all shares held of record by Healthcare in which the GPLLC does not have an actual pecuniary interest.
Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Healthcare. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Healthcare in which he does not have an actual pecuniary interest.